Advanced search
Publication Cover
OncoImmunology Volume 1, 2012 - Issue 7
Submit an article Journal homepage
641
Views
10
CrossRef citations to date
0
Altmetric
Author's View

Rapamycin

A rheostat for CD8+ T-cell-mediated tumor therapy

Rupesh K. Srivastava Department of Immunology; Roswell Park Cancer Institute; Buffalo, NY USA
,
Adam Utley Department of Immunology; Roswell Park Cancer Institute; Buffalo, NY USA
&
Protul A. Shrikant Department of Immunology; Roswell Park Cancer Institute; Buffalo, NY USACorrespondence[email protected]
Pages 1189-1190 | Received 04 May 2012, Accepted 07 May 2012, Published online: 01 Oct 2012

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mikhail V Blagosklonny. (2013) Immunosuppressants in cancer prevention and therapy. OncoImmunology 2:12.
Read now

Articles from other publishers (9)

Jia Yuan, Xianlin Yuan, Kunlong Wu, Junxia Gao & Liangping Li. (2021) A Local and Low-Dose Chemotherapy/Autophagy-Enhancing Regimen Treatment Markedly Inhibited the Growth of Established Solid Tumors Through a Systemic Antitumor Immune Response. Frontiers in Oncology 11.
Crossref
Alexandre el Hage & Olivier Dormond. (2021) Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. Cancers 13:6, pages 1359.
Crossref
Vidula V. Sukhatme, Suresh S. Ramalingam, Rafi Ahmed & Vikas P. Sukhatme. (2019) Repurposing Food and Drug Administration–Approved Drugs to Promote Antitumor Immunity. The Cancer Journal 25:2, pages 88-99.
Crossref
Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, Libia A. Luevano, Melissa Wolf, Uday Baliga, Carsten Krieg, Craig C. Beeson, Meenal Mehrotra, Elizabeth G. Hill, Jeffery C. Rathmell, Xue-Zhong Yu, Andrew S. Kraft & Shikhar Mehrotra. (2019) Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clinical Cancer Research 25:3, pages 1036-1049.
Crossref
Xiaoyan Liu, Qing Zhou, Yan Xu, Minjiang Chen, Jing Zhao & Mengzhao Wang. (2017) Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?. Oncotarget 8:49, pages 86969-86984.
Crossref
Joseph D. Coppock & John H. Lee. (2016) mTOR, metabolism, and the immune response in HPV‐positive head and neck squamous cell cancer. World Journal of Otorhinolaryngology - Head and Neck Surgery 2:2, pages 76-83.
Crossref
José Manuel Bravo-San Pedro & Laura Senovilla. (2013) Immunostimulatory activity of lifespan-extending agents. Aging 5:11, pages 793-801.
Crossref
Joseph D. Coppock, Bryant G. Wieking, Alfredo A. Molinolo, J. Silvio Gutkind, W. Keith Miskimins & John H. Lee. (2013) Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition. Neoplasia 15:6, pages 620-IN10.
Crossref
Antoni Ribas & Jedd D Wolchok. (2013) Combining cancer immunotherapy and targeted therapy. Current Opinion in Immunology 25:2, pages 291-296.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.